Continue current treatment: raloxifene
Raloxifene should not be used in women who have or have had any blood clot disorders,
including deep vein thrombosis and pulmonary embolism. Based on the recommendation for
thromboembolism prophylaxis for 35 days after a hip fracture, a higher risk for fracture
patients over 35 days may be expected. Therefore, a drug holiday for 35 days is recommended.
Literature
- http://www.ema.europa.eu
- Falck-Ytter Y, Francis CW, Johanson NA, et al.
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e278S–325S.
<%= buttons %>